Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1573876

Cover Image

PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1573876

AI in Life Science Analytics Market, Opportunity, Growth Drivers, Industry Trend Analysis and Forecast, 2024-2032

PUBLISHED:
PAGES: 100 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 4850
PDF & Excel (Multi User License)
USD 5350
PDF & Excel (Enterprise User License)
USD 8350

Add to Cart

The Global AI in Life Science Analytics Market was valued at USD 1.3 billion in 2023 and is projected to grow at a CAGR of 11.5% from 2024 to 2032. The market, driven by AI technologies, is growing due to the rising demand for advanced data analytics to enhance pharmaceutical and biotechnology R&D processes.

AI-driven analytics revolutionize the life sciences sector by facilitating precise data interpretation, streamlining drug discovery, and refining clinical trials. Automated machine learning algorithms predict patient outcomes and identify potential drug candidates. Natural language processing (NLP) tools analyze unstructured data from scientific literature and electronic health records, discovering novel biomarkers and therapeutic targets.

The surge in AI adoption within life sciences is driven by the escalating data volumes from genomics, proteomics, and other omics technologies, necessitating advanced analytical tools for actionable insights. Pharmaceutical firms invest heavily in AI to hasten drug development and reduce clinical trial costs.

AI personalizes medicine by forecasting patient responses to treatments, enhancing outcomes, and minimizing adverse effects. Regulatory bodies, including the FDA, promote AI's integration in drug development by issuing usage guidelines, accelerating technology adoption.

The overall AI in life science analytics industry is classified based on component, application, deployment, end-use, and region.

In 2023, the sales and marketing support segment led with a revenue of USD 516.4 million. This growth is due to the adoption of AI-driven solutions that enhance sales effectiveness, customer engagement, and market intelligence in life sciences. AI enables companies to customize interactions and strategies based on individual preferences, behaviors, and historical data. By analyzing extensive datasets-ranging from customer profiles and purchasing patterns to market trends-AI algorithms and advanced analytics enable precise audience segmentation and targeted marketing campaigns.

The cloud-based segment led in 2023 and is projected to reach USD 2 billion by 2032. This growth is driven by the cloud's scalability, flexibility, and cost benefits. Cloud service providers offer AI-centric tools and services, streamlining the development, training, and deployment of machine learning models in life sciences. These platforms provide pre-built AI algorithms, model development frameworks, and automated workflows, streamlining AI lifecycle management. For instance, Microsoft Azure offers budget-friendly AI solutions for life sciences, including AI-driven analytics and machine learning tools. Azure's adaptable pricing and comprehensive cloud services help organizations maximize research budgets and enhance operational efficiency through scalable AI implementations.

North America AI in life science analytics market accounted for USD 490.0 million in 2023, with a projected CAGR of 10.8% from 2024 to 2032. This growth is due to the region's heightened AI adoption for drug discovery, clinical trials, and personalized medicine. Companies use AI to analyze vast datasets, derive insights, and expedite R&D. Pfizer, for example, uses AI to predict drug interactions and refine clinical trial designs, reducing time and costs. Collaborations like the one between IBM Watson Health and Pfizer highlight the trend of tech-pharma partnerships, further driving the region's market growth.

Product Code: 11104

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Market scope and definitions
  • 1.2 Research design
    • 1.2.1 Research approach
    • 1.2.2 Data collection methods
  • 1.3 Base estimates and calculations
    • 1.3.1 Base year calculation
    • 1.3.2 Key trends for market estimation
  • 1.4 Forecast model
  • 1.5 Primary research and validation
    • 1.5.1 Primary sources
    • 1.5.2 Data mining sources

Chapter 2 Executive Summary

  • 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

  • 3.1 Industry ecosystem analysis
  • 3.2 Industry impact forces
    • 3.2.1 Growth drivers
      • 3.2.1.1 Rising demand for efficient drug discovery
      • 3.2.1.2 Personalized medicine solutions
      • 3.2.1.3 Advancements in AI algorithms and computational capabilities
      • 3.2.1.4 Increasing volume of complex healthcare data
    • 3.2.2 Industry pitfalls and challenges
      • 3.2.2.1 Data privacy and security concerns
      • 3.2.2.2 High initial investment costs
  • 3.3 Growth potential analysis
  • 3.4 Regulatory landscape
  • 3.5 Innovation landscape
  • 3.6 Porter's analysis
  • 3.7 PESTEL analysis
  • 3.8 Future market trends
  • 3.9 Gap analysis
  • 3.10 The impact of artificial intelligence in life sciences

Chapter 4 Competitive Landscape, 2023

  • 4.1 Introduction
  • 4.2 Company matrix analysis
  • 4.3 Competitive analysis of major key players
  • 4.4 Competitive positioning matrix
  • 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Component, 2021 - 2032 ($ Mn)

  • 5.1 Key trends
  • 5.2 Services
  • 5.3 Software
  • 5.4 Hardware

Chapter 6 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

  • 6.1 Key trends
  • 6.2 Sales and marketing support
  • 6.3 Supply chain analytics
  • 6.4 Research and development
  • 6.5 Other applications

Chapter 7 Market Estimates and Forecast, By Deployment, 2021 - 2032 ($ Mn)

  • 7.1 Key trends
  • 7.2 Cloud-based
  • 7.3 On-premises

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

  • 8.1 Key trends
  • 8.2 Pharmaceutical and biotech companies
  • 8.3 Medical device manufacturers
  • 8.4 Contract research organizations
  • 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

  • 9.1 Key trends
  • 9.2 North America
    • 9.2.1 U.S.
    • 9.2.2 Canada
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 France
    • 9.3.4 Spain
    • 9.3.5 Italy
    • 9.3.6 Netherlands
    • 9.3.7 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 China
    • 9.4.2 Japan
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 South Korea
    • 9.4.6 Rest of Asia Pacific
  • 9.5 Latin America
    • 9.5.1 Brazil
    • 9.5.2 Mexico
    • 9.5.3 Argentina
    • 9.5.4 Rest of Latin America
  • 9.6 Middle East and Africa
    • 9.6.1 South Africa
    • 9.6.2 Saudi Arabia
    • 9.6.3 UAE
    • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

  • 10.1 AiCure LLC
  • 10.2 Atomwise
  • 10.3 Axtria
  • 10.4 Databricks
  • 10.5 IBM Corporation
  • 10.6 Indegene
  • 10.7 Lexalytics
  • 10.8 Nuance communications
  • 10.9 NuMedii
  • 10.10 Oracle Corporation
  • 10.11 Saama
  • 10.12 SAS Institute, Inc.
  • 10.13 Sisense
  • 10.14 Sorcero
  • 10.15 Tempus AI
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!